<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0" xmlns:creativeCommons="http://backend.userland.com/creativeCommonsRssModule" xmlns:dc="http://purl.org/dc/elements/1.1/">

<channel>
<title>Cytokinetics Incorporated  Company Newsfeed</title>
<link>http://www.advfn.com/nasdaq/rss.asp?symbol=CYTK</link>
<description>Cytokinetics Incorporated  Company Newsfeed</description>
<language>en</language>
<pubDate>Fri, 09 Dec 2011 11:05:46 EST</pubDate>
<lastBuildDate>Fri, 09 Dec 2011 11:05:46 EST</lastBuildDate>
  
  
 <item>
 <title>Registration Effectiveness Orders Issued By The SEC</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=CYTK&amp;article=50371835&amp;headline=registration-effectiveness-orders-issued-by-the-sec</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=CYTK&amp;article=50371835&amp;headline=registration-effectiveness-orders-issued-by-the-sec</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; The following table includes registration statements and post-effective amendments that were declared effective by the Securities and Exchange Commission on the most recently completed business day. &#60;/p&#62;
&#60;p&#62; The Securities Act of 1933 requires companies offering securities to...</description>
 <pubDate>Fri, 09 Dec 2011 11:05:46 EST</pubDate>
 </item>

 <item>
 <title>US Stock Futures: HOT STOCKS TO WATCH</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=CYTK&amp;article=49594483&amp;headline=us-stock-futures-hot-stocks-to-watch</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=CYTK&amp;article=49594483&amp;headline=us-stock-futures-hot-stocks-to-watch</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; Among the companies whose shares are expected to actively trade in Wednesday's session are Apple Inc. (AAPL), Intel Corp. (INTC) and Abbott Laboratories (ABT). &#60;/p&#62;
&#60;p&#62; Apple Inc.'s (AAPL) fiscal fourth-quarter earnings surged 54% but missed expectations as sales of the company's...</description>
 <pubDate>Wed, 19 Oct 2011 09:25:38 EDT</pubDate>
 </item>

 <item>
 <title>Cytokinetics Shares Slump As It Ends Collaboration With Glaxo</title>
 <link>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=CYTK&amp;article=40706179&amp;headline=cytokinetics-shares-slump-as-it-ends-collaboration-with-glaxo</link>
 <guid>http://www.advfn.com/nasdaq/StockNews.asp?stocknews=CYTK&amp;article=40706179&amp;headline=cytokinetics-shares-slump-as-it-ends-collaboration-with-glaxo</guid>
 <description>&#60;div class='newsbody'&#62;&#60;p&#62; DOW JONES NEWSWIRES &#60;/p&#62;
&#60;p&#62; Cytokinetics Inc. (CYTK) and GlaxoSmithKline PLC (GSK) have agreed to end their cancer-drug collaboration and license agreement on Feb. 28, a move the biopharmaceutical company said &#34;reinforces&#34; the company's push to focus on internal research related...</description>
 <pubDate>Wed, 09 Dec 2009 16:46:07 EST</pubDate>
 </item>

</channel>
</rss>